Logo image of PRA

PROASSURANCE CORP (PRA) Stock Fundamental Analysis

NYSE:PRA - New York Stock Exchange, Inc. - US74267C1062 - Common Stock - Currency: USD

22.9  -0.02 (-0.09%)

After market: 22.9 0 (0%)

Fundamental Rating

2

Taking everything into account, PRA scores 2 out of 10 in our fundamental rating. PRA was compared to 144 industry peers in the Insurance industry. Both the profitability and financial health of PRA have multiple concerns. PRA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year PRA was profitable.
PRA had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PRA reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: PRA reported negative operating cash flow in multiple years.
PRA Yearly Net Income VS EBIT VS OCF VS FCFPRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

With a Return On Assets value of 0.77%, PRA is not doing good in the industry: 61.81% of the companies in the same industry are doing better.
PRA has a worse Return On Equity (3.43%) than 77.08% of its industry peers.
With a Return On Invested Capital value of 0.90%, PRA perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for PRA is below the industry average of 4.08%.
The last Return On Invested Capital (0.90%) for PRA is above the 3 year average (0.50%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.77%
ROE 3.43%
ROIC 0.9%
ROA(3y)0.08%
ROA(5y)-0.24%
ROE(3y)0.29%
ROE(5y)-0.41%
ROIC(3y)0.5%
ROIC(5y)N/A
PRA Yearly ROA, ROE, ROICPRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

With a Profit Margin value of 3.76%, PRA is not doing good in the industry: 69.44% of the companies in the same industry are doing better.
PRA's Profit Margin has improved in the last couple of years.
PRA has a worse Operating Margin (5.27%) than 73.61% of its industry peers.
In the last couple of years the Operating Margin of PRA has grown nicely.
Industry RankSector Rank
OM 5.27%
PM (TTM) 3.76%
GM N/A
OM growth 3Y13.27%
OM growth 5Y78.9%
PM growth 3Y-29.65%
PM growth 5Y116.12%
GM growth 3YN/A
GM growth 5YN/A
PRA Yearly Profit, Operating, Gross MarginsPRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRA is destroying value.
PRA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, PRA has less shares outstanding
The debt/assets ratio for PRA is higher compared to a year ago.
PRA Yearly Shares OutstandingPRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
PRA Yearly Total Debt VS Total AssetsPRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

A Debt/Equity ratio of 0.34 indicates that PRA is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.34, PRA perfoms like the industry average, outperforming 45.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.1
WACC9.4%
PRA Yearly LT Debt VS Equity VS FCFPRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
PRA Yearly Current Assets VS Current LiabilitesPRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

4

3. Growth

3.1 Past

PRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 783.33%, which is quite impressive.
The Earnings Per Share has been growing by 119.92% on average over the past years. This is a very strong growth
PRA shows a decrease in Revenue. In the last year, the revenue decreased by -1.39%.
PRA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.27% yearly.
EPS 1Y (TTM)783.33%
EPS 3Y-10.31%
EPS 5Y119.92%
EPS Q2Q%62.5%
Revenue 1Y (TTM)-1.39%
Revenue growth 3Y1.68%
Revenue growth 5Y2.27%
Sales Q2Q%-2.42%

3.2 Future

The Earnings Per Share is expected to grow by 10.52% on average over the next years. This is quite good.
The Revenue is expected to decrease by -0.41% on average over the next years.
EPS Next Y-13%
EPS Next 2Y1.49%
EPS Next 3Y10.52%
EPS Next 5YN/A
Revenue Next Year-1.88%
Revenue Next 2Y-0.33%
Revenue Next 3Y-0.41%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PRA Yearly Revenue VS EstimatesPRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
PRA Yearly EPS VS EstimatesPRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.60 indicates a rather expensive valuation of PRA.
Based on the Price/Earnings ratio, PRA is valued a bit more expensive than the industry average as 67.36% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 26.34, PRA is valued at the same level.
Based on the Price/Forward Earnings ratio of 22.01, the valuation of PRA can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PRA indicates a slightly more expensive valuation: PRA is more expensive than 70.83% of the companies listed in the same industry.
PRA is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.6
Fwd PE 22.01
PRA Price Earnings VS Forward Price EarningsPRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

63.19% of the companies in the same industry are cheaper than PRA, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.55
PRA Per share dataPRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.18
EPS Next 2Y1.49%
EPS Next 3Y10.52%

3

5. Dividend

5.1 Amount

PRA has a Yearly Dividend Yield of 1.55%. Purely for dividend investing, there may be better candidates out there.
PRA's Dividend Yield is comparable with the industry average which is at 3.52.
Compared to the average S&P500 Dividend Yield of 2.44, PRA is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.55%

5.2 History

PRA has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
PRA Yearly Dividends per sharePRA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.5 1 1.5

5.3 Sustainability

DP0%
EPS Next 2Y1.49%
EPS Next 3Y10.52%
PRA Yearly Income VS Free CF VS DividendPRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

PROASSURANCE CORP

NYSE:PRA (6/20/2025, 8:04:00 PM)

After market: 22.9 0 (0%)

22.9

-0.02 (-0.09%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners86.97%
Inst Owner Change-0.92%
Ins Owners1.29%
Ins Owner Change7.37%
Market Cap1.17B
Analysts49.23
Price Target23.12 (0.96%)
Short Float %5.37%
Short Ratio3.84
Dividend
Industry RankSector Rank
Dividend Yield 1.55%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)38.18%
Min EPS beat(2)-34.55%
Max EPS beat(2)110.91%
EPS beat(4)3
Avg EPS beat(4)83.77%
Min EPS beat(4)-34.55%
Max EPS beat(4)137.62%
EPS beat(8)5
Avg EPS beat(8)11.77%
EPS beat(12)6
Avg EPS beat(12)-9.85%
EPS beat(16)9
Avg EPS beat(16)53%
Revenue beat(2)0
Avg Revenue beat(2)-1.75%
Min Revenue beat(2)-1.98%
Max Revenue beat(2)-1.53%
Revenue beat(4)0
Avg Revenue beat(4)-3.65%
Min Revenue beat(4)-7.47%
Max Revenue beat(4)-1.53%
Revenue beat(8)1
Avg Revenue beat(8)-3.48%
Revenue beat(12)3
Avg Revenue beat(12)-1.05%
Revenue beat(16)5
Avg Revenue beat(16)1.72%
PT rev (1m)11.48%
PT rev (3m)24.2%
EPS NQ rev (1m)-5.62%
EPS NQ rev (3m)-5.62%
EPS NY rev (1m)-7.2%
EPS NY rev (3m)-0.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.78%
Revenue NY rev (1m)-0.67%
Revenue NY rev (3m)-3.24%
Valuation
Industry RankSector Rank
PE 21.6
Fwd PE 22.01
P/S 1.04
P/FCF N/A
P/OCF N/A
P/B 0.95
P/tB 1
EV/EBITDA 20.55
EPS(TTM)1.06
EY4.63%
EPS(NY)1.04
Fwd EY4.54%
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS22
BVpS24.16
TBVpS23.02
PEG (NY)N/A
PEG (5Y)0.18
Profitability
Industry RankSector Rank
ROA 0.77%
ROE 3.43%
ROCE 1.07%
ROIC 0.9%
ROICexc 0.91%
ROICexgc 1.02%
OM 5.27%
PM (TTM) 3.76%
GM N/A
FCFM N/A
ROA(3y)0.08%
ROA(5y)-0.24%
ROE(3y)0.29%
ROE(5y)-0.41%
ROIC(3y)0.5%
ROIC(5y)N/A
ROICexc(3y)0.51%
ROICexc(5y)N/A
ROICexgc(3y)0.58%
ROICexgc(5y)N/A
ROCE(3y)0.6%
ROCE(5y)N/A
ROICexcg growth 3Y18.48%
ROICexcg growth 5Y73.91%
ROICexc growth 3Y18.73%
ROICexc growth 5Y76.59%
OM growth 3Y13.27%
OM growth 5Y78.9%
PM growth 3Y-29.65%
PM growth 5Y116.12%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA 5.62
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC9.4%
ROIC/WACC0.1
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)783.33%
EPS 3Y-10.31%
EPS 5Y119.92%
EPS Q2Q%62.5%
EPS Next Y-13%
EPS Next 2Y1.49%
EPS Next 3Y10.52%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.39%
Revenue growth 3Y1.68%
Revenue growth 5Y2.27%
Sales Q2Q%-2.42%
Revenue Next Year-1.88%
Revenue Next 2Y-0.33%
Revenue Next 3Y-0.41%
Revenue Next 5YN/A
EBIT growth 1Y66.59%
EBIT growth 3Y15.18%
EBIT growth 5Y82.96%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y85.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.56%
OCF growth 3YN/A
OCF growth 5YN/A